Product Code: ETC6190098 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The inhalers market in Australia is mature and highly regulated, comprising metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs). Popular treatments for asthma and COPD are delivered via these devices. Innovations in smart inhalers, which monitor patient adherence and medication usage, are gaining traction in chronic disease management.
Inhalers remain a cornerstone in the management of asthma and COPD in Australia. The market is witnessing increased uptake of smart inhalers that track usage and adherence. Dry powder inhalers (DPIs) are becoming more popular due to ease of use and portability. Pharmaceutical companies are targeting device innovation to improve patient outcomes.
Improper usage of inhalers due to inadequate patient education is a key concern in this market. Additionally, the transition to eco-friendly propellants in metered-dose inhalers increases production complexity and costs. Regulatory and reimbursement policies also impact market penetration.
Australias respiratory inhalers market is ripe for investment due to the rising prevalence of asthma and COPD, particularly among the elderly and youth populations. There is strong demand for smart inhalers that sync with mobile apps for dosage tracking and adherence. Investors can also explore eco-friendly inhaler propellants and innovative delivery mechanisms for long-term growth.
The government facilitates market growth through PBS subsidies for both metered-dose and dry powder inhalers used in treating asthma and COPD. Policies also encourage education programs to improve inhaler technique and adherence. The TGA oversees the approval process, while initiatives like the National Asthma Strategy support better accessibility and usage of inhalers in communities.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Respiratory Inhalers Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Respiratory Inhalers Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Respiratory Inhalers Market - Industry Life Cycle |
3.4 Australia Respiratory Inhalers Market - Porter's Five Forces |
3.5 Australia Respiratory Inhalers Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Respiratory Inhalers Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.7 Australia Respiratory Inhalers Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Australia Respiratory Inhalers Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Australia Respiratory Inhalers Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Australia Respiratory Inhalers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Respiratory Inhalers Market Trends |
6 Australia Respiratory Inhalers Market, By Types |
6.1 Australia Respiratory Inhalers Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Respiratory Inhalers Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Respiratory Inhalers Market Revenues & Volume, By Dry Powder Inhaler, 2021- 2031F |
6.1.4 Australia Respiratory Inhalers Market Revenues & Volume, By Metered Dose Inhaler, 2021- 2031F |
6.1.5 Australia Respiratory Inhalers Market Revenues & Volume, By Soft Mist Inhalers, 2021- 2031F |
6.1.6 Australia Respiratory Inhalers Market Revenues & Volume, By Nebulizer, 2021- 2031F |
6.2 Australia Respiratory Inhalers Market, By Patient |
6.2.1 Overview and Analysis |
6.2.2 Australia Respiratory Inhalers Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 Australia Respiratory Inhalers Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3 Australia Respiratory Inhalers Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Respiratory Inhalers Market Revenues & Volume, By Manually Operated Inhaler Devices, 2021- 2031F |
6.3.3 Australia Respiratory Inhalers Market Revenues & Volume, By Digitally Operated Inhaler Devices, 2021- 2031F |
6.4 Australia Respiratory Inhalers Market, By Disease Indication |
6.4.1 Overview and Analysis |
6.4.2 Australia Respiratory Inhalers Market Revenues & Volume, By Asthma, 2021- 2031F |
6.4.3 Australia Respiratory Inhalers Market Revenues & Volume, By Chronic Obstructive Pulmonary Disease (COPD), 2021- 2031F |
6.4.4 Australia Respiratory Inhalers Market Revenues & Volume, By Pulmonary Arteial Hypertention, 2021- 2031F |
6.4.5 Australia Respiratory Inhalers Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Respiratory Inhalers Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 Australia Respiratory Inhalers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Respiratory Inhalers Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.4 Australia Respiratory Inhalers Market Revenues & Volume, By Pharmacies, 2021- 2031F |
6.5.5 Australia Respiratory Inhalers Market Revenues & Volume, By Respiratory Care Center, 2021- 2031F |
6.5.6 Australia Respiratory Inhalers Market Revenues & Volume, By Other, 2021- 2031F |
7 Australia Respiratory Inhalers Market Import-Export Trade Statistics |
7.1 Australia Respiratory Inhalers Market Export to Major Countries |
7.2 Australia Respiratory Inhalers Market Imports from Major Countries |
8 Australia Respiratory Inhalers Market Key Performance Indicators |
9 Australia Respiratory Inhalers Market - Opportunity Assessment |
9.1 Australia Respiratory Inhalers Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Respiratory Inhalers Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.3 Australia Respiratory Inhalers Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Australia Respiratory Inhalers Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.5 Australia Respiratory Inhalers Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Australia Respiratory Inhalers Market - Competitive Landscape |
10.1 Australia Respiratory Inhalers Market Revenue Share, By Companies, 2024 |
10.2 Australia Respiratory Inhalers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |